semaglutide appendicitis Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its side effects range from common GI symptoms to rare but serious risks. ⸻ 🟡 Common PDF) Appendicitis After Initiation of

Access and Equity Considerations The high cost of GLP-1 RAs raises major concerns about health equity and access

What to track weekly Body weight: Weigh yourself at the same time each week, same day, same conditions

Patient concerns: Three female patients with median age of 34 (range 2746) presented to the oral medicine clinic with chief complaint of xerostomia

SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment

Within CBT models, such reductions are understood as a lowering of cue-reactivity and hedonic drive, two core maintaining mechanisms of overeating and binge-type behavior

GLP-1 medications are highly regulated they go through years of clinical trials to collect sufficient data on the drugs safety and effectiveness before theyre approved for use